AC
ICCC icon

Antara Capital’s ImmuCell ICCC Stock Holding History

Antara Capital’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-105,000
Closed -$541K – 48
2019
Q4 		$541K Hold
105,000
– – 0.11% 45
2019
Q3 		$582K Hold
105,000
– – 0.27% 26
2019
Q2 		$682K Hold
105,000
– – 0.15% 48
2019
Q1 		$666K Buy
+105,000
New +$750K 0.19% 44

Other funds holding ICCC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Antara Capital's ICCC Position: Q1 2020 in Review

Antara Capital sold out of ImmuCell (ICCC) in Q1 2020, closing a stake of 105,000 shares — an estimated $541K sold.

Antara Capital first reported a position in ICCC in Q1 2019 and held it in 4 quarters. The position peaked at $682K in Q2 2019. 21 funds tracked by Wall St. Rank hold ICCC as of Q1 2020.

  • Antara Capital reported no remaining ImmuCell position as of Q1 2020 after selling out during the quarter.
  • Antara Capital sold 105,000 ImmuCell shares in Q1 2020, an estimated $541K.
  • Antara Capital first reported a position in ImmuCell in Q1 2019 and held it in 4 quarters.
  • Antara Capital's ImmuCell position peaked at $682K in Q2 2019.
  • 21 funds tracked by Wall St. Rank held ImmuCell as of Q1 2020.

Based on Antara Capital's 13F filing for Q1 2020, filed 14 May 2020.